Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model

Reprod Biol Endocrinol. 2012 Dec 29:10:117. doi: 10.1186/1477-7827-10-117.

Abstract

Background: Advancing female age remains a difficult problem in infertility treatment. Ovarian angiogenesis plays an important role in follicular development and the activation of ovarian angiogenesis has been emerged as a new strategy for the improvement of age-related decline of oocyte quality. BMP-6 affect gonadotropin signals in granulosa cells and it promotes normal fertility by enabling appropriate response to LH and normal oocyte quality. BMP-6 has a potential role in regulation of angiogenesis and regulates the expression of inhibitor of DNA-binding proteins (Ids). Ids involved in the control and timing of follicle selection and granulosa cells differentiation. Especially, Id-1 is well-characterized target of BMP-6 signaling. Therefore, this study investigated whether co-administration of BMP-6 during superovulation process improves ovarian response, oocyte quality and expression of Id-1 and vascular endothelial growth factor (VEGF) in the ovary of aged female using a mouse model.

Methods: Aged C57BL/6 female mice (26-31 weeks old) were superovulated by injection with 0.1 mL of 5 IU equine chorionic gonadotropin (eCG) containing recombinant mouse BMP-6 at various doses (0, 0.01, 0.1, 1, and 10 ng), followed by injection with 5 IU human chorionic gonadotropin (hCG) 48 h later. Then, the mice were immediately paired with an individual male. The aged control group was superovulated without BMP-6. Young mice of 6-9 weeks old were superovulated without BMP-6 as a positive control for superovulation and in vitro culture of embryos. Eighteen hours after hCG injection, zygotes were retrieved and cultured for 4 days. Both ovaries of each mouse were provided in the examination of ovarian expression of Id-1 and VEGF by reverse transcriptase-polymerase chain reaction, western blot, and immunohistochemistry.

Results: Administration of 0.1 ng BMP-6 significantly increased the number and blastocyst formation rate of oocytes ovulated and ovarian expression of Id-1 and VEGF compared to aged control mice. These increased levels were comparable to those of young control mice.

Conclusions: This result suggests that BMP-6 during ovulation induction plays an important role in improvement of oocyte quality and ovarian response of aged female, possibly by regulating of ovarian Id-1 and VEGF expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects*
  • Aging / metabolism
  • Aging / physiology
  • Animals
  • Bone Morphogenetic Protein 6 / administration & dosage*
  • Cells, Cultured
  • Female
  • Infertility, Female / drug therapy*
  • Infertility, Female / metabolism
  • Infertility, Female / physiopathology
  • Inhibitor of Differentiation Protein 1 / biosynthesis
  • Mice
  • Mice, Inbred C57BL
  • Models, Animal*
  • Oocytes / drug effects*
  • Oocytes / physiology
  • Ovary / drug effects
  • Ovary / metabolism
  • Ovary / physiology
  • Ovulation Induction / methods*
  • Vascular Endothelial Growth Factor A / biosynthesis

Substances

  • Bone Morphogenetic Protein 6
  • Inhibitor of Differentiation Protein 1
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse